Western Michigan University Homer Stryker M.D. School of Medicine is a private medical school in Kalamazoo, Michigan. WMed was established in 2012 and confers the Doctor of Medicine degree, as well as Master of Science in Biomedical Sciences degree and the Master of Science in Medical Engineering degree.

During the past decade, Kalamazoo Center for Medical Studies conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 31 clinical trials were completed, i.e. on average, 387.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kalamazoo Center for Medical Studies" #1 sponsor was "Children's Oncology Group" with 38 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "Celgene" with 3 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "American Regent, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kalamazoo Center for Medical Studies" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Kalamazoo Center for Medical Studies" are "Acute Lymphoblastic Leukemia" (7 trials), "Adult Rhabdomyosarcoma" (4 trials), "Childhood B Acute Lymphoblastic Leukemia" (4 trials), "Childhood Alveolar Rhabdomyosarcoma" (3 trials) and "Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma" (3 trials). Many other conditions were trialed in "Kalamazoo Center for Medical Studies" in a lesser frequency.

Most popular intervention types in "Kalamazoo Center for Medical Studies" are "Drug" (39 trials), "Other" (39 trials), "Biological" (21 trials), "Radiation" (15 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Cyclophosphamide" (16 trials), "Doxorubicin Hydrochloride" (15 trials), "Vincristine Sulfate" (14 trials) and "Cytology Specimen Collection Procedure" (10 trials). Other intervention names were less common.

The vast majority of trials in "Kalamazoo Center for Medical Studies" are 53 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kalamazoo Center for Medical Studies". undefined are not yet recruiting, 8 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Kalamazoo Center for Medical Studies, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kalamazoo Center for Medical Studies, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".